COMPASS PATHWAYS PLC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
COMPASS PATHWAYS PLC (CMPS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $4.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $4.03M, a 11.99% increase year-over-year.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.90M, a 26.40% decline year-over-year.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.21M, a 35.51% decline year-over-year.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.60M, a 26.93% decline year-over-year.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $13.59M, a 30.37% decline from fiscal 2024.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $19.52M, a 12.97% increase from fiscal 2023.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $17.28M, a 31.65% increase from fiscal 2022.
- COMPASS PATHWAYS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $13.12M, a 51.90% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.03M 10-Q · filed 2026-08-05 | $6.92M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $2.90M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $13.59M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | $3.21M 10-Q · filed 2025-11-04 | $6.80M derived: sum of 2 quarters · filed 2026-08-05 | $10.74M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $3.60M 10-Q · filed 2026-08-05 | $7.53M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $3.94M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $19.52M 10-K · filed 2026-03-24 | |||
| 2024-09-30 | $4.97M 10-Q · filed 2025-11-04 | $9.89M derived: sum of 2 quarters · filed 2025-11-04 | $15.02M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $4.92M 10-Q · filed 2025-11-04 | $10.05M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $5.13M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $17.28M 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $4.45M 10-Q · filed 2024-10-31 | $9.01M derived: sum of 2 quarters · filed 2024-10-31 | $13.08M derived: sum of 3 quarters · filed 2024-10-31 | |
| 2023-06-30 | $4.56M 10-Q · filed 2024-10-31 | $8.63M derived: sum of 2 quarters · filed 2024-10-31 | ||
| 2023-03-31 | $4.07M 10-Q · filed 2024-10-31 | |||
| 2022-12-31 | $13.12M 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $3.50M 10-Q · filed 2023-11-02 | $6.68M derived: sum of 2 quarters · filed 2023-11-02 | $9.81M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $3.18M 10-Q · filed 2023-11-02 | $6.31M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $3.13M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $8.64M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $2.29M 10-Q · filed 2022-11-03 | $4.19M derived: sum of 2 quarters · filed 2022-11-03 | $5.86M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $1.90M 10-Q · filed 2022-11-03 | $3.57M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $1.67M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $17.98M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $5.21M 6-K · filed 2021-11-09 | $14.91M derived: sum of 2 quarters · filed 2021-11-09 | $16.62M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $9.70M 6-K · filed 2021-11-09 | $11.40M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $1.70M 6-K · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |